Guanfacine Extended-Release Tablets

PRODUCT DETAILS

  • RLD: INTUNIV®
  • Strength: Available in 1 mg, 2 mg, 3 mg, and 4 mg Tablets
  • Therapeutic Class: Alpha Agonist

StrengthNDC NumberSaleable UnitWholesaler Numbers
1 mg70436-039-01Bottle of 100Cardinal Health: 5792544
McKesson: 2626687
Amerisource: 10269549
2 mg70436-040-01Bottle of 100Cardinal Health: 5792551
McKesson: 2626679
Amerisource: 10269833
3 mg70436-041-01Bottle of 100Cardinal Health: 5792569
McKesson: 2626661
Amerisource: 10269840
4 mg70436-042-01Bottle of 100Cardinal Health: 5792577
McKesson: 2626653
Amerisource: 10269524

1 mg, white to off-white biconvex round tablets, debossed with “YH” on one side and “116” on the other side.

2 mg, white to off-white biconvex caplets, debossed with “YH” on one side and “117” on the other side.

3 mg, orange biconvex round tablets, debossed with “YH” on one side and “118” on the other side.

4 mg, orange biconvex caplets, debossed with “YH” on one side and “119” on the other side.

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature].

We have been made aware of recent scams that offer false employment opportunities or request financial commitments purportedly on behalf of Slate Run Pharmaceuticals. Unsuspecting job seekers have reported receiving unsolicited contacts such as e-mails and phone calls which may request personal information or offers of employment. Please note that these communications are fraudulent and are not affiliated with Slate Run Pharmaceuticals. Slate Run Pharmaceuticals never requires a financial deposit for employment consideration nor do we offer unsolicited employment packages.

You can reach out to Slate Run Pharmaceuticals at http://www.slaterunpharma.com/get-in-touch/. If you receive a suspicious proposal, please contact your local law enforcement agency for guidance.